We actively collaborate with our colleagues in the University of Iowa Institute for Vision Research in the study of blinding diseases including Bardet-Biedl syndrome, Best disease, Stargardt disease, Leber congenital amaurosis, retinitis pigmentosa, choroideremia, glaucoma, and other acquired and inherited diseases of the retina.

Our laboratory employs a multidisciplinary approach involving donated human eyes, cell culture models including induced pluripotent stem cells, mouse models, and anatomical, molecular, and functional studies. It is our goal to use this knowledge to improve treatments and ultimately develop cures for the millions of individuals whose sight is threatened by retinal and choroidal diseases.

Recent News

  • Thu, 05/09/2019 - 15:30

    Postdoctoral Research Scholar Kelly Mulfaul was honored with the 2019 Members-in-Training (MIT) Outstanding Poster Award in the Retinal Cell Biology category for her poster, “Choroidal Endothelial Cells Synthesize CFH Locally to Protect Against Complement Mediated Injury” at the annual meeting of

  • Rab5a-Positive Endosomes in RF/6A Cells
    Wed, 10/31/2018 - 15:00

    Our lab recently published a paper describing the identification of compounds that protect the cells of the choroid (the vascular system that supports rod and cone photoreceptor cells) from injury by the complement system, a major source of cell injury in age-related macular degeneration.

  • Tue, 04/03/2018 - 14:30

    Dr. Robert Mullins was honored with the Inaugural RPB David F. Weeks Award for Outstanding AMD Research from the Association of University Professors in Ophthalmology on January 26th, 2018 during the group's 2018 Annual Meeting in Austin, Texas.